Chemistry professors in Germany are calling for an investigation into potential unintended proteins in mRNA vaccines. The concerns were raised in a letter to BioNTech founder Ugur Sahin by four renowned scientists. The professors are seeking clarity on the production process and demanding information about the toxicity of unintended proteins. They also question the approval process and point out discrepancies between the original approval studies and broad application. The professors are urging the Paul-Ehrlich-Institut to take action to restore trust in mRNA technology and ultimately halt the use of modRNA vaccines.
While some may dismiss these concerns as unfounded conspiracy theories, there are healthcare professionals and researchers who believe in the benefits of vaccines but are raising concerns about the adverse effects and unexplained deaths associated with COVID-19 mRNA vaccines. Scientific studies have shown potential risks, such as an elevated risk of myocarditis and pericarditis, as well as the formation of unintended proteins and DNA contaminants after vaccination. These issues deserve thorough investigation before the vaccines can be considered safe for use.
The fast-track approvals of these vaccines and the lack of transparency in the process are also raising questions. It is important for concerned individuals to come forward, mobilize, and advocate for the banning of these vaccines until they can be proven to be 100 percent safe. The implications for vaccine safety and public health are being closely scrutinized and discussed.
It is crucial to note that these concerns should not undermine the importance of vaccination in controlling the spread of COVID-19. Vaccines have played a significant role in reducing the severity of the disease and preventing hospitalizations and deaths. However, it is equally important to ensure the safety and efficacy of vaccines through rigorous testing and transparent research. The concerns raised by these chemistry professors highlight the need for ongoing evaluation and monitoring of vaccine safety.
The Paul-Ehrlich-Institut and other regulatory bodies should take these concerns seriously and conduct thorough investigations into the production process and potential risks associated with mRNA vaccines. Transparency and communication are key in maintaining public trust in vaccines and ensuring the safety of the population. Only through open dialogue and extensive research can we address these concerns and make informed decisions regarding the use of mRNA vaccines.
In conclusion, chemistry professors in Germany are calling for an investigation into potential unintended proteins in mRNA vaccines. Their concerns regarding the production process, toxicity of unintended proteins, and discrepancies in the approval process raise important questions about vaccine safety. While vaccination remains a crucial tool in combating COVID-19, it is essential to address these concerns through thorough investigation and transparent research to ensure the safety and efficacy of mRNA vaccines.